This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warren, J.
Right arrow Articles by Botto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warren, J.
Right arrow Articles by Botto, M.

 Previous Article  |  Next Article 

Infection and Immunity, February 2002, p. 551-557, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.551-557.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Increased Susceptibility of C1q-Deficient Mice to Salmonella enterica Serovar Typhimurium Infection

Joanna Warren,1 Pietro Mastroeni,2 Gordon Dougan,3 Mahdad Noursadeghi,4 Jonathan Cohen,4 Mark J. Walport,1 and Marina Botto1*

Rheumatology Section, Division of Medicine,1 Departments of Biochemistry,3 Infectious Diseases, Imperial College School of Medicine London,4 Centre for Veterinary Science, University of Cambridge, Cambridge, United Kingdom2

Received 9 July 2001/ Returned for modification 27 September 2001/ Accepted 7 November 2001

The role of the complement system in host defense against Salmonella infection is poorly defined. Bacterial cell wall O-antigen polysaccharide can activate the alternative pathway in vitro. No studies, however, have elucidated the role of the classical pathway in immunity to Salmonella spp. in vivo. C1q-deficient mice (C1qa-/-) on a 129/Sv genetic background and strain-matched controls were infected intraperitoneally and intravenously with Salmonella enterica serovar Typhimurium and monitored over a 14-day period. After inoculation by either route, the C1qa-/- mice were found to be significantly more susceptible to Salmonella infection. Hepatic and splenic bacterial counts, performed at various time points, showed increased numbers of colonies in complement-deficient mice compared to controls. Analysis of blood clearance showed no difference between the two experimental groups during the first 15 min. However, after 20 min and until 6 h postinfection, numbers of circulating bacteria were significantly higher in complement-deficient mice. In vitro experiments using either resident or thioglycolate-elicited peritoneal macrophages showed a significant increase in the number of bacteria inside C1q-deficient macrophages compared to controls irrespective of the serum used for opsonizing the bacteria. These findings could not be explained either by an increased bacterial uptake, analyzed in vitro and in vivo using green fluorescent protein-tagged salmonellae, or by a defect in the respiratory burst or in NO production. The data presented here suggest the possibility of novel pathways by which C1q may modulate the pathogenesis of infectious diseases caused by intracellular pathogens.


* Corresponding author. Mailing address: Rheumatology Section, Division of Medicine, Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London W12 ONN, United Kingdom. Phone: 44 20 8383 2316. Fax: 44 20 8743 3109. E-mail: m.botto{at}ic.ac.uk.

Editor: S. H. E. Kaufmann


Infection and Immunity, February 2002, p. 551-557, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.551-557.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Benhnia, M. R.-E.-I., McCausland, M. M., Laudenslager, J., Granger, S. W., Rickert, S., Koriazova, L., Tahara, T., Kubo, R. T., Kato, S., Crotty, S. (2009). Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5. J. Virol. 83: 12355-12367 [Abstract] [Full Text]  
  • Yuste, J., Sen, A., Truedsson, L., Jonsson, G., Tay, L.-S., Hyams, C., Baxendale, H. E., Goldblatt, F., Botto, M., Brown, J. S. (2008). Impaired Opsonization with C3b and Phagocytosis of Streptococcus pneumoniae in Sera from Subjects with Defects in the Classical Complement Pathway. Infect. Immun. 76: 3761-3770 [Abstract] [Full Text]  
  • Lillis, A. P., Greenlee, M. C., Mikhailenko, I., Pizzo, S. V., Tenner, A. J., Strickland, D. K., Bohlson, S. S. (2008). Murine Low-Density Lipoprotein Receptor-Related Protein 1 (LRP) Is Required for Phagocytosis of Targets Bearing LRP Ligands but Is Not Required for C1q-Triggered Enhancement of Phagocytosis. J. Immunol. 181: 364-373 [Abstract] [Full Text]  
  • Yuste, J., Ali, S., Sriskandan, S., Hyams, C., Botto, M., Brown, J. S. (2006). Roles of the Alternative Complement Pathway and C1q during Innate Immunity to Streptococcus pyogenes. J. Immunol. 176: 6112-6120 [Abstract] [Full Text]  
  • Mastroeni,, P., Menager, N. (2003). Development of acquired immunity to Salmonella. J Med Microbiol 52: 453-459 [Abstract] [Full Text]  
  • Brown, J. S., Hussell, T., Gilliland, S. M., Holden, D. W., Paton, J. C., Ehrenstein, M. R., Walport, M. J., Botto, M. (2002). The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. USA 99: 16969-16974 [Abstract] [Full Text]